(NASDAQ: WGS) Genedx Holdings's forecast annual revenue growth rate of 7.96% is forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 3.67%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 8.74%.
Genedx Holdings's revenue in 2024 is $267,228,000.On average, 1 Wall Street analysts forecast WGS's revenue for 2024 to be $7,925,498,035, with the lowest WGS revenue forecast at $7,925,498,035, and the highest WGS revenue forecast at $7,925,498,035.
In 2025, WGS is forecast to generate $9,073,802,429 in revenue, with the lowest revenue forecast at $9,073,802,429 and the highest revenue forecast at $9,073,802,429.